GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ANPEP | 500 | LTM | Hepatic Cancer | NA | HAK-1B | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.0117 | 24325739
|
PROM1 | 9454 | LTM | Hepatic Cancer | NA | HAK-1B | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.7582 | 24325739
|
ABCG2 | 74 | LTM | Hepatic Cancer | NA | HAK-1B | NA | SP assay followed by qRT-PCR | NA | 0.2 | 0.1739 | 24325739
|
BMI1 | 1066 | LTM | Hepatic Cancer | NA | HAK-1B | NA | SP assay followed by qRT-PCR | NA | 0.2 | 0.1135 | 24325739
|
CD24 | 1645 | LTM | Hepatic Cancer | NA | HAK-1B | NA | SP assay followed by qRT-PCR | NA | 0.2 | 0.456 | 24325739
|
CD44 | 1681 | LTM | Hepatic Cancer | NA | HAK-1B | NA | SP assay followed by qRT-PCR | NA | 0.2 | 1 | 24325739
|
EPCAM | 11529 | LTM | Hepatic Cancer | NA | HAK-1B | NA | SP assay followed by qRT-PCR | NA | 0.2 | 0.211 | 24325739
|
NANOG | 20857 | LTM | Hepatic Cancer | NA | HAK-1B | NA | SP assay followed by qRT-PCR | NA | 0.2 | 0.5461 | 24325739
|